Search

Your search keyword '"Kukin ML"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Kukin ML" Remove constraint Author: "Kukin ML"
36 results on '"Kukin ML"'

Search Results

1. Clinical trials report

2. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.

4. Public perception of heart failure on twitter: A sentiment analysis.

5. Current Management and Future Directions of Heart Failure With Preserved Ejection Fraction: a Contemporary Review.

6. Farewell to PCVD.

7. Malnutrition as assessed by nutritional risk index is associated with worse outcome in patients admitted with acute decompensated heart failure: an ACAP-HF data analysis.

9. Beta-blockers in chronic heart failure: considerations for selecting an agent.

10. Are all beta blockers the same for heart failure?

11. Beta-blockers and spironolactone in heart failure.

12. Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.

13. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators.

14. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure.

15. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.

16. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.

17. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.

18. Noninvasive measurement of cardiac output by an acetylene uptake technique and simultaneous comparison with thermodilution in ICU patients.

19. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

20. Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure.

21. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.

22. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

23. Lymphocyte G proteins reflect response to treatment in congestive heart failure.

24. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.

25. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).

27. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

28. Management of patients with heart failure and angina: do coexistent diseases alter the response to cardiovascular drugs?

29. The erythrocyte sedimentation rate in congestive heart failure.

30. Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure.

31. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure.

32. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.

33. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure.

34. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure.

35. The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure.

36. Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.

Catalog

Books, media, physical & digital resources